Officiële publicaties MaaT Pharma

Aandelen

Real Time Euronext Paris Andere beurzen 11:17:47 05-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,9 ^EUR	0,00%		-1,25%	+13,18%

15/04	MaaT Pharma presenteert positieve 18-maandse gegevens voor MaaT013 die een duidelijk algemeen overlevingsvoordeel laten zien bij aGvHD uit het Early Access-programma op het EBMT-evenement van 2024	CI
08/04	MaaT Pharma presenteert veelbelovende preklinische gegevens op AACR voor MaaT034, dat gericht is op het verbeteren van de? reacties op immuuntherapieën te verbeteren	CI

Monthly statement on voting rights	31/01	CO
Shareholder letter	31/01	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	18/01	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	17/01	CO
Monthly statement on voting rights	31/12	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	30/11	CO
3rd quarter turnover	09/11	CO
3rd quarter turnover	09/11	CO
Monthly statement on voting rights	31-10-23	CO
Monthly statement on voting rights	31-10-23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	29-09-23	CO
1st-half-year results	26-09-23	CO
1st-half-year results	26-09-23	CO
Half-year report	26-09-23	CO
Monthly statement on voting rights	31-07-23	CO
Monthly statement on voting rights	31-07-23	CO
2nd quarter turnover	27-07-23	CO
2nd quarter turnover	27-07-23	CO
Monthly statement on voting rights	30-06-23	CO
Monthly statement on voting rights	30-06-23	CO
Changes in management and corporate officers	21-06-23	CO
Changes in management and corporate officers	21-06-23	CO
Shareholders meeting voting results	19-06-23	CO